Ofra Barnett-Griness obtained her Ph.D. in Statistics in 1998, after which she has been working within the pharmaceutical industry providing statistical expertise in various strategic roles across multiple therapeutic areas, focusing on Oncology. Ofra joined Bioforum in June 2019, to provide statistical leadership for overall and individual study strategy for our customers. She consults on aspects of study design, endpoint selection, sample size considerations, and advance statistical methodology. These incudes regulatory with FDA and other agencies. Ofra gained experience in teaching statistics where she aims at bringing the valuable biostatistics concepts and tools to the statisticians and non-statisticians audience.